Get the Stockscreener App
2.00
1.96%
-0.04
After Hours:
2.09
0.09
+4.50%
Lisata Therapeutics Inc stock is traded at $2.00, with a volume of 13,660.
It is down -1.96% in the last 24 hours and down -7.41% over the past month.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
See More
Previous Close:
$2.04
Open:
$1.98
24h Volume:
13,660
Relative Volume:
0.21
Market Cap:
$17.64M
Revenue:
-
Net Income/Loss:
$-20.74M
P/E Ratio:
-0.7968
EPS:
-2.51
Net Cash Flow:
$-18.90M
1W Performance:
+1.52%
1M Performance:
-7.41%
6M Performance:
-21.84%
1Y Performance:
-26.74%
1-Day Range:
$1.98
$2.15
1-Week Range:
$1.92
$2.16
52-Week Range:
$1.81
$4.20
Lisata Therapeutics Inc Stock (LSTA) Company Profile
Name
Lisata Therapeutics Inc
Sector
Industry
Phone
908-229-2590
Address
110 ALLEN ROAD, BASKING RIDGE
Compare LSTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LSTA
Lisata Therapeutics Inc
|
2.00 | 17.99M | 0 | -20.74M | -18.90M | -2.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lisata Therapeutics Inc Stock (LSTA) Latest News
Aug Weekly: Will Lisata Therapeutics Inc stock see insider buying2025 Investor Takeaways & Expert Approved Momentum Trade Ideas - moha.gov.vn
Lisata Therapeutics Inc 8NE Stock Analysis and ForecastEvening Star Patterns & Affordable Trading Growth - earlytimes.in
Why institutional investors increase stakes in Lisata Therapeutics Inc. (8NE) stockJuly 2025 Market Mood & Safe Entry Momentum Tips - Newser
Why Lisata Therapeutics Inc. (8NE) stock attracts wealthy investorsJuly 2025 Recap & Growth Focused Stock Reports - Newser
Is Lisata Therapeutics Inc. (8NE) stock undervalued by metricsEarnings Overview Summary & Risk Managed Trade Strategies - Newser
Is Lisata Therapeutics Inc. stock a smart buy before Fed meetingTrade Exit Report & Consistent Profit Alerts - Newser
Can Lisata Therapeutics Inc. (8NE) stock hit consensus price targets2025 Top Decliners & Daily Growth Stock Investment Tips - Newser
Is Lisata Therapeutics Inc. (8NE) stock suitable for passive index fundsJuly 2025 Drop Watch & Verified Technical Trade Signals - Newser
Lisata Therapeutics (LSTA) Stock Analysis Report | Financials & Insights - Benzinga
Why Lisata Therapeutics Inc. stock is popular among millennials2025 Investor Takeaways & Weekly Chart Analysis and Guides - Newser
Will Lisata Therapeutics Inc. (8NE) stock beat revenue estimatesMarket Trend Review & Free Technical Confirmation Trade Alerts - Newser
What analysts say about Lisata Therapeutics Inc stockMomentum Trading Signals & Market Trend Real-Time Reports - earlytimes.in
Will Lisata Therapeutics Inc. stock sustain high P E ratios2025 Risk Factors & Expert Curated Trade Setups - newser.com
Will Lisata Therapeutics Inc. (8NE) stock keep high P E multiplesJuly 2025 Reactions & High Accuracy Trade Signal Alerts - newser.com
Lisata Therapeutics (LSTA) Price Target Decreased by 37.10% to 13.26 - MSN
Is now a turning point for Lisata Therapeutics Inc.2025 Support & Resistance & Daily Risk Controlled Trade Plans - newser.com
Automated trading signals detected on Lisata Therapeutics Inc.Watch List & Stepwise Entry and Exit Trade Signals - newser.com
Is Lisata Therapeutics Inc. reversing from oversold territoryEarnings Growth Summary & Stock Portfolio Risk Control - newser.com
How Lisata Therapeutics Inc. (8NE) stock performs during market turbulence2025 Market Sentiment & Daily Market Momentum Tracking - newser.com
Will Lisata Therapeutics Inc. (8NE) stock see valuation expansionTrade Ideas & Free Verified High Yield Trade Plans - newser.com
Can Lisata Therapeutics Inc. stock continue upward trendJuly 2025 Institutional & Weekly High Potential Stock Alerts - newser.com
Why Lisata Therapeutics Inc. stock is recommended by analysts2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com
Developing predictive dashboards with Lisata Therapeutics Inc. dataWeekly Stock Report & Safe Swing Trade Setups - newser.com
Can Lisata Therapeutics Inc. stock weather global recessionPortfolio Update Report & High Yield Stock Recommendations - newser.com
Smart tools for monitoring Lisata Therapeutics Inc.’s price action2025 Geopolitical Influence & Low Risk Entry Point Tips - newser.com
Why Lisata Therapeutics Inc. stock is rated strong buyEarnings Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Using Bollinger Bands to evaluate Lisata Therapeutics Inc.2025 Top Gainers & Smart Investment Allocation Tips - newser.com
Original-Research: Lisata Therapeutics Inc (von First Berlin Equity Research GmbH): BUY - TradingView
Is Lisata Therapeutics Inc. (8NE) stock cheap vs fundamentalsQuarterly Earnings Summary & Fast Gain Stock Trading Tips - newser.com
Is Lisata Therapeutics Inc. stock reversal real or fakeTrade Ideas & Intraday High Probability Setup Alerts - newser.com
Key metrics from Lisata Therapeutics Inc.’s quarterly dataJuly 2025 Volume & Consistent Profit Trading Strategies - newser.com
Lisata Therapeutics Inc Stock (LSTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):